In an exclusive conversation with HT Digital, Kushagra reflects on the journey that began with reaching out to seniors ended ...
Analyst/Investor Day July 15, 2026 9:00 AM EDTCompany ParticipantsJan-Hendrik Mohr - Chairman of Management Board & ...
A new AAV-based gene therapy successfully improved seizures, behavior, and brain activity in fragile X syndrome mice, paving the way for clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results